BioCatalystFeed / Readout calendar / FDA decisions / Drugs / Disease areas / Companies / Months

Biotech catalysts in 2027-05

0 industry Phase 2/3 trial readout(s) and 2 FDA decision event(s). Active trials only; estimated dates often slip.

← 2027-04 | 2027-06 →

FDA decision events

DateEventStatusCompanyDrugSource
2027-05-01PDUFA date (company-disclosed)pendinguniQure N.V. QUREifezuntirgenePDUFA May 1, 2027 - uniQure N.V. (ifezuntirgene)
2027-05-01PDUFA date (company-disclosed)pendingAxsome Therapeutics, Inc. AXSMPDUFA May 1, 2027 - Axsome Therapeutics, Inc.

Trial readouts

ReadoutPhaseSponsorTrialConditionsStatusEnrollment
No trials in this window.

← 2027-04 | 2027-06 →

Readout = ClinicalTrials.gov primary completion date (sponsor-reported; est. dates often slip; top-line results usually follow weeks to months later). FDA events: PDUFA dates are extracted from company 8-K filings (SEC EDGAR) and are company-disclosed and UNVERIFIED - read the filing; AdCom meetings come from Federal Register notices; approvals from Drugs@FDA (openFDA); complete response letters from openFDA (published with a lag). Tickers are matched by name with a confidence score. Generated 2026-11-18T17:57:33Z. Same data: bcf readouts search, bcf fda-decisions search, MCP readout_calendar / fda_decisions. Not investment advice.